Skip to main content
PROVEXIS PLC logo

PROVEXIS PLC — Investor Relations & Filings

Ticker · PXS ISIN · GB00B0923P27 LEI · 21380042E3Y3N9VZ6N48 IL Professional, scientific and technical activities
Open in API
Filings indexed 207 across all filing types
Latest filing 2015-01-19 Regulatory Filings
Country GB United Kingdom
Listing IL PXS

About PROVEXIS PLC

https://www.provexis.org/

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1183 characters) and announces a specific, temporary operational event related to trading: a 'Price Monitoring Extension' for the closing auction call period for the security. It explicitly states that the information is provided by 'RNS - The company news service from the London Stock Exchange'. This type of brief, operational market announcement that doesn't fit into specific financial reporting categories (like ER, 10-K, or DIV) is best classified as a general regulatory filing or announcement, which corresponds to the 'Regulatory Filings' category (RNS) or potentially a specific operational notice. Given the source attribution ('RNS Number') and the nature of the content (a trading mechanism update rather than a financial result or corporate governance change), RNS is the most appropriate fit as a general regulatory announcement fallback.
2015-01-19 English
Half Yearly Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'UNAUDITED INTERIM RESULTS FOR SIX MONTHS TO 30 SEPTEMBER 2014' and contains comprehensive financial statements, including a Consolidated Statement of Comprehensive Income, for a period shorter than a full fiscal year. It provides substantive financial data and management analysis, fitting the definition of an Interim/Quarterly Report (IR). H1 2014
2014-12-30 English
Draw Down of Funds and Issue of Equity
Capital/Financing Update Classification · 98% confidence The document is an official announcement filed under RNS Number 1876Z on December 9, 2014. The title explicitly states 'Draw Down of Funds and Issue of Equity'. It details the process of drawing down funds from an Equity Financing Facility and the subsequent allotment and admission of new ordinary shares. This activity directly relates to the company's capital structure and fundraising efforts. Therefore, the most appropriate classification is Capital/Financing Update (CAP). Although it is an RNS filing, the content is highly specific to financing, making CAP a better fit than the general RNS fallback.
2014-12-09 English
Re-appointment to the Scientific Advisory Board
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated 01 December 2014. The content announces the re-appointment of a professor to the Scientific Advisory Board and references previous announcements and agreements. This type of announcement, which is a formal update to the market regarding corporate governance/personnel changes, is typically disseminated via the Regulatory News Service (RNS). Since the specific categories (like MANG for board changes) do not perfectly capture this specific type of advisory board update, and given the explicit 'RNS Number' and 'This information is provided by RNS' footer, the most appropriate general classification is Regulatory Filings (RNS). It is not a full report (10-K, IR), an earnings release (ER), or a director's dealing (DIRS).
2014-12-01 English
Collaboration with the University of Oslo
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and is dated 18 November 2014. The content announces a collaboration agreement, research findings related to Fruitflow®, and the subsequent 'Issue of share options' to key personnel. This type of announcement, which details operational updates, research progress, and insider transactions (option grants), is characteristic of a general regulatory news service release. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a formal dividend notice (DIV), the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly labeled as an RNS release and contains miscellaneous corporate news.
2014-11-18 English
Group of companies' accounts made up to 2014-03-31
Regulatory Filings
2014-10-02 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.